AI-generated summary
The authors describe leukoderma (loss of skin pigment) that followed toning with a Q-switched 1064-nm Nd:YAG laser, which they say is usually hard to treat and is thought to result from cumulative damage to melanocytes. They report that epidermal grafting may replenish hypopigmented areas with melanocytes without worsening melasma, while NB-UVB and 308-nm excimer treatments may worsen melasma. Evidence strength is not stated in the abstract.
- Who or what was studied
- unclear
- Wavelengths
- 1064, 308 nm
- Limits stated in the abstract
- The abstract does not state the number of patients or any outcome data, so the reported benefit of epidermal grafting cannot be assessed from it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.